ArticleDiabetic medicine : a journal of the British Diabetic Association2026
Under- and overdosing insulin in the hospital: A retrospective cohort study of dose deviation and patient outcomes.
Article in Diabetic medicine : a journal of the British Diabetic Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsGlycaemic abnormalities during hospitalization are common and linked to morbidity and mortality, yet little is known about how deviations from guideline-recommended insulin dosing affect outcomes. The aim of this study is to examine whether deviation from an expected insulin dose in non-critically ill hospitalized adults with type 2 diabetes, compared with guideline-concordant dosing, is associated with mortality, length of stay or dysglycaemias.
methodsThis retrospective cohort study included adults with type 2 diabetes hospitalized at a tertiary academic medical centre (2010-2025) who received ≥ 24 h of subcutaneous insulin. The expected total daily insulin dose (TDID) was calculated based on guideline-concordant dosing using the ADA-recommended range (0.3-0.6 units/kg/day), and the observed TDID was derived from medication records. Patients were classified as undertreated (< 0.3 units/kg/day), guideline-concordant (0.3-0.6 units/kg/day) or overtreated (> 0.6 units/kg/day). Outcomes included length of stay, and 30-day mortality, hypoglycaemia and hyperglycaemia.
resultsAmong 3430 hospitalized adults with type 2 diabetes receiving subcutaneous insulin, 37.6% received guideline-concordant dosing, 43.7% were undertreated, and 18.7% were overtreated. Undertreatment was independently associated with increased 30-day mortality (aHR 1.273, 95% CI 1.024-1.583; p = 0.03), while overtreatment was not. Undertreated patients had more hyperglycaemia and longer hospital stays (p < 0.001), whereas hypoglycaemia rates were similar between groups.
conclusionDeviation from guideline-based insulin dosing is common in hospitalized adults with type 2 diabetes. Undertreatment was associated with increased 30-day mortality and prolonged hospitalization. Monitoring insulin dose deviation may help identify patients at risk for adverse outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.